TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35796800

Group type: EXPERIMENTAL
Intervention: Potassium oxalate (Oxa-Gel BF)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Low-power laser irradiation (LL)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Potassium oxalate (Oxa-Gel BF) associated with low-power laser irradiation (POLL)
Number of subjects: 74
Study: 33059959

Group type: EXPERIMENTAL
Intervention: PopART intervention (universal home-based HIV testing, linkage to care, ART adherence, and other services)
Number of subjects: 128241

Group type: EXPERIMENTAL
Intervention: PopART intervention
Number of subjects: 128241
Study: 32281361

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with modified Xiangfu Decoction
Number of subjects: 120

Group type: COMPARATOR
Intervention: Estazolam
Number of subjects: 120
Study: 35166158

Group type: COMPARATOR
Intervention: Psilocybin-assisted treatment with supportive psychotherapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Psilocybin-assisted treatment
Number of subjects: 27
Study: 33770708

Group type: EXPERIMENTAL
Intervention: Extended interval dosing (EID) regimen (MDI 6.1 weeks)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Standard interval dosing (SID) regimen (MDI 4.5 weeks)
Number of subjects: 316
Study: 34952745

Group type: EXPERIMENTAL
Intervention: ED-LINC intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 40
Study: 33539991

Group type: EXPERIMENTAL
Intervention: Total Worker Health intervention with active workstations and additional support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual practice control with active workstations and no additional support
Number of subjects: 0
Study: 32722731

Group type: EXPERIMENTAL
Intervention: Biweekly yoga
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Weekly yoga
Number of subjects: 3
Study: 35007153

Group type: EXPERIMENTAL
Intervention: Paclitaxel and Carboplatin (PC)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Paclitaxel and Ifosfamide (PI)
Number of subjects: 449
Study: 33676296

Group type: EXPERIMENTAL
Intervention: Systemic lidocaine (1.5 mg kg−1 bolus, followed by 2 mg kg−1 h−1 infusion)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.9% saline (identical volumes and rates)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Systemic lidocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 100
Study: 32770840

Group type: EXPERIMENTAL
Intervention: MgSO4 infusion (30 mg/kg loading dose followed by 10 mg/kg/hr continuous infusion)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% saline (same loading and maintenance infusion rates as MgSO4)
Number of subjects: 40
Study: 34904450

Group type: EXPERIMENTAL
Intervention: Povidone iodine protocol (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Surveillance without povidone iodine (Group B)
Number of subjects: 40
Study: 32788274

Group type: EXPERIMENTAL
Intervention: 20 min mindful breathing and standard care
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 40
Study: 34570024

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nonaerobic stretching and toning (SAT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Healthy control (HC)
Number of subjects: 19
Study: 33864331

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Virtual simulation
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Case study
Number of subjects: 59
Study: 35556860

Group type: EXPERIMENTAL
Intervention: Jigsaw active learning technique
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Jigsaw active learning technique (using peer-created teaching materials)
Number of subjects: 21
Study: 33852547

Group type: EXPERIMENTAL
Intervention: PM2.5 exposure
Number of subjects: 10035

Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 10035
Study: 33729371

Group type: EXPERIMENTAL
Intervention: Mobile application for cell phones (Intervention Group - IG)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control Group (CG) - attended prenatal consultations without the application
Number of subjects: 88
Study: 32573271

Group type: EXPERIMENTAL
Intervention: Double-adjustable AFO (DA AFO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Posterior leaf spring AFO (PLS AFO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Practice with either AFO
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: DA AFO
Number of subjects: 20

Group type: COMPARATOR
Intervention: PLS AFO
Number of subjects: 20
Study: 35886305

Group type: COMPARATOR
Intervention: Muay Thai
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Brazilian jiu-jitsu
Number of subjects: 30
Study: 34721629

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with rehabilitation training
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham procedures
Number of subjects: 56
Study: 36384234

Group type: EXPERIMENTAL
Intervention: Mobile Palliative Care Link (mPCL)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Phone-contact POS collection
Number of subjects: 49
Study: 35613785

Group type: EXPERIMENTAL
Intervention: Norming strategy for HIV testing
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard strategy for HIV testing
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Norming strategy
Number of subjects: 198
Study: 33874994

Group type: EXPERIMENTAL
Intervention: Mobile App (RheumaLive) for documenting disease activity
Number of subjects: 60

Group type: COMPARATOR
Intervention: Paper-based PROMs (Hannover Functional Questionnaire/derived HAQ)
Number of subjects: 60
Study: 32490976

Group type: EXPERIMENTAL
Intervention: Baerveldt glaucoma implant (250-mm2)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Mitomycin-augmented trabeculectomy
Number of subjects: 13
Study: 35450683

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 610
Study: 32077050

Group type: EXPERIMENTAL
Intervention: Planning intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 33416200

Group type: EXPERIMENTAL
Intervention: ipragliflozin
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: sitagliptin
Number of subjects: 111
Study: 32327091

Group type: EXPERIMENTAL
Intervention: Fractional flow reserve (FFR) measurement in non-infarct-related arteries (non-IRAs) after successful primary percutaneous coronary intervention
Number of subjects: 751
Study: 35976662

Group type: EXPERIMENTAL
Intervention: High autistic traits (HAT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low autistic traits (LAT)
Number of subjects: 0
Study: 32629295

Group type: EXPERIMENTAL
Intervention: Transcatheter InterAtrial Shunt Device (IASD)
Number of subjects: 608

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 608
Study: 34255327

Group type: EXPERIMENTAL
Intervention: Mobility and stability exercises during warm-up for 10 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual warm-up
Number of subjects: 32
Study: 35786650

Group type: EXPERIMENTAL
Intervention: Enhanced Cued Recall test (ECR)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Auditory Verbal Learning Test (AVLT)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Logical Memory test (LM)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Cognitive testing based on the Uniform Data Set battery
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Rey-Osterrieth Complex Figure test
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Cued recall paradigm (CECR)
Number of subjects: 270
Study: 32947549

Group type: EXPERIMENTAL
Intervention: Liberal postoperative activity recommendations (no limitations on physical activity)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Restricted postoperative activity recommendations (heavy lifting and high-impact activity prohibited)
Number of subjects: 95
Study: 32757658

Group type: EXPERIMENTAL
Intervention: tPA dosing regimens for ultrasound-facilitated, catheter-directed fibrinolysis (8 mg/2 hours, 8 mg/4 hours, 12 mg/6 hours, and 24 mg/6 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tPA dosing regimens for ultrasound-facilitated, catheter-directed fibrinolysis
Number of subjects: 0
Study: 36401325

Group type: EXPERIMENTAL
Intervention: Manual Acupuncture (MA)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sham Acupuncture (SA)
Number of subjects: 108
Study: 32144974

Group type: EXPERIMENTAL
Intervention: Intra-articular oxygen-ozone therapy (O2O3)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 42
Study: 35721497

Group type: EXPERIMENTAL
Intervention: Plasmalogen (2 mg per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32988373

Group type: EXPERIMENTAL
Intervention: Single IV dose of fosaprepitant 150 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control regimen)
Number of subjects: 0
Study: 36806623

Group type: EXPERIMENTAL
Intervention: 0.9 mg of 0.1% oestradiol gel per day
Number of subjects: 78

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 78
Study: 35945496

Group type: EXPERIMENTAL
Intervention: Culturally-adapted Otago Exercise Program (OEP) delivered by community health representatives (CHR) for 6 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard of care education-based fall risk management
Number of subjects: 200
Study: 34323575

Group type: EXPERIMENTAL
Intervention: Weight losers (n = 88)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Weight maintainers (n = 143)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Overall treatment group (including weight losers and maintainers)
Number of subjects: 231
Study: 35433384

Group type: EXPERIMENTAL
Intervention: 300 mg of oral magnesium powder
Number of subjects: 100

Group type: COMPARATOR
Intervention: Starch powder (control)
Number of subjects: 100
Study: 32761473

Group type: EXPERIMENTAL
Intervention: Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco)
Number of subjects: 68

Group type: COMPARATOR
Intervention: PPV and deferred phaco
Number of subjects: 68
Study: 34143954

Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis EVC001
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32386418

Group type: EXPERIMENTAL
Intervention: Negative outcome expectancy (NOE) vignette
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Positive outcome expectancy (POE) vignette
Number of subjects: 257

Group type: COMPARATOR
Intervention: Standard care vignette
Number of subjects: 257
Study: 33463492

Group type: EXPERIMENTAL
Intervention: Fat-modified enteral nutrition (EN) suspension
Number of subjects: 141
Study: 33428632

Group type: EXPERIMENTAL
Intervention: KRdc (Carfilzomib, Lenalidomide, Dexamethasone, Cyclophosphamide)
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Control (Tdc/Rdc - Thalidomide, Dexamethasone, Cyclophosphamide or Lenalidomide, Dexamethasone, Cyclophosphamide)
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: KRdc
Number of subjects: 1056
Study: 34872040

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% plus dexamethasone 8 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ropivacaine 0.2% plus placebo
Number of subjects: 60
Study: 34176932

Group type: EXPERIMENTAL
Intervention: Intravenous landiolol (started at 3 μg/min/kg dose and continued to a total of 50 mg; n=23)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (n=24)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Intravenous landiolol (n=23)
Number of subjects: 47
Study: 33228846

Group type: EXPERIMENTAL
Intervention: Open urethroplasty
Number of subjects: 222

Group type: COMPARATOR
Intervention: Endoscopic urethrotomy
Number of subjects: 222
Study: 33440062

Group type: EXPERIMENTAL
Intervention: Robotic-assisted surgery (da Vinci Xi system)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 300
Study: 33158931

Group type: EXPERIMENTAL
Intervention: Genetically predicted PCOS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no PCOS)
Number of subjects: 0
Study: 32708446

Group type: EXPERIMENTAL
Intervention: Donkey milk-derived human milk fortifier (DF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bovine milk-derived fortifier (BF)
Number of subjects: 10
Study: 35514746

Group type: EXPERIMENTAL
Intervention: Povidone-iodine 0.5% and glycyrrhizic acid 2.5 mg/ml
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 35844134

Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV) monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34312485

Group type: EXPERIMENTAL
Intervention: Idiopathic pulmonary fibrosis (IPF) patients
Number of subjects: 42777

Group type: COMPARATOR
Intervention: General population (control)
Number of subjects: 42777
Study: 34225830

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over rIFC combined with cognitive training (20 min, 1 mA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham tDCS over rIFC combined with cognitive training (20 min, 1 mA)
Number of subjects: 50
Study: 35015856

Group type: EXPERIMENTAL
Intervention: standard micronutrient powder (MNP) containing 4.1 mg zinc and 10 mg iron, daily
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: high-zinc (10 mg), low-iron (6 mg) (HiZn LoFe) MNP, daily
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: HiZn (10 mg) LoFe (6 mg)/HiZn (10 mg), no-iron MNPs on alternating days
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: dispersible zinc tablet (10 mg), daily
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: dispersible zinc tablet (10 mg), daily for 2 wk at enrollment and 12 wk
Number of subjects: 2886

Group type: COMPARATOR
Intervention: placebo powder, daily
Number of subjects: 2886
Study: 32026478

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting lung cancer-specific survival (LCSS)
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Risk classification system based on the nomogram
Number of subjects: 988
Study: 34649742

Group type: EXPERIMENTAL
Intervention: Early mobilization after trapeziectomy (n = 28)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Postoperative regimen with rigid orthosis and mobilization after 6 weeks (n = 27)
Number of subjects: 59
Study: 32881567

Group type: EXPERIMENTAL
Intervention: Poor targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wealthy targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prosocial behavior of poor targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prosocial behavior of wealthy targets
Number of subjects: 0
Study: 32100933

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) mouthwash
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) mouthwash
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Antioxidant mouthwash
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All mouthwashes
Number of subjects: 75
Study: 35306827

Group type: EXPERIMENTAL
Intervention: Deferoxamine
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 32222326

Group type: EXPERIMENTAL
Intervention: Physical activity intervention including 5 key messages, personalized activity suggestions, and support from a Registered Kinesiologist.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (as above)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study: 33310174

Group type: EXPERIMENTAL
Intervention: 10 g leucine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 10 g isoleucine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 32453774

Group type: EXPERIMENTAL
Intervention: Guided counseling based on the health belief model and the theory of planned behavior; four counseling sessions.
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Guided counseling; dietary diversity.
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Guided counseling; meal frequency.
Number of subjects: 346

Group type: COMPARATOR
Intervention: Routine nutrition education (Control);
Number of subjects: 346
Study: 33877875

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35776026

Group type: COMPARATOR
Intervention: Disposable cystoscope
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Reusable cystoscope
Number of subjects: 128
Study: 33876547

Group type: EXPERIMENTAL
Intervention: Smartphone-controlled patch electro-acupuncture (SCEA)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: SCEA
Number of subjects: 37
Study: 34161807

Group type: EXPERIMENTAL
Intervention: Home-based mobile device designed to enhance self-care behavior
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 118
Study: 32088254

Group type: EXPERIMENTAL
Intervention: Calculation method with interruption defined as ≥ 1 s
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Calculation method with interruption defined as ≥ 2 s
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Calculation method with interruption defined as ≥ 3 s
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Calculation method #3 excluding top and bottom quartiles
Number of subjects: 200
Study: 35123694

Group type: EXPERIMENTAL
Intervention: Trametinib 2 mg once daily
Number of subjects: 260

Group type: COMPARATOR
Intervention: Standard-of-care (intravenous paclitaxel, pegylated liposomal doxorubicin, topotecan, oral letrozole, or oral tamoxifen)
Number of subjects: 260
Study: 34051963

Group type: COMPARATOR
Intervention: Essential oil mouthwash with alcohol (control)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Essential oil mouthwash without alcohol (test)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both groups (control and test)
Number of subjects: 11
Study: 32945733

Group type: EXPERIMENTAL
Intervention: Additional counseling that encouraged a discussion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard informed consent for cesarean birth
Number of subjects: 0
Study: 32186047

Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion (HPM)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 640
Study: 35466696

Group type: EXPERIMENTAL
Intervention: Powerlifting exercise
Number of subjects: 64

Group type: COMPARATOR
Intervention: Bodyweight exercise
Number of subjects: 64
Study: 34559801

Group type: EXPERIMENTAL
Intervention: Azithromycin (20mg/kg, biannual single-dose)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 614
Study: 35217193

Group type: EXPERIMENTAL
Intervention: Dance training (DG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Balance training (BG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study: 32240156

Group type: EXPERIMENTAL
Intervention: PopART intervention (Arm A)
Number of subjects: 193907

Group type: EXPERIMENTAL
Intervention: PopART intervention (Arm B)
Number of subjects: 193907

Group type: COMPARATOR
Intervention: Standard-of-care (Arm C)
Number of subjects: 193907
Study: 34491646

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with medication
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medication (oxiracetam capsules, 2 capsules, 3 times a day)
Number of subjects: 120
Study: 36330567

Group type: EXPERIMENTAL
Intervention: Active drug use (sertraline, fluvoxamine, risperidone, fluoxetine)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Early improvement in CGI-I (score of ≤3 at Week 1)
Number of subjects: 599
Study: 33634319

Group type: EXPERIMENTAL
Intervention: Low-iron MNP (5 mg iron)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard MNP (12.5 mg iron)
Number of subjects: 53
Study: 32121466

Group type: EXPERIMENTAL
Intervention: Dynamic Artificial Intelligence (AI) model using three different BLE advertising channels to detect human body shadowing and compensate RSSI values.
Number of subjects: 0
Study: 35179586

Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg) with capecitabine (850 or 1000 mg/m2) and bevacizumab (7.5 mg/kg)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo with capecitabine (850 or 1000 mg/m2) and bevacizumab (7.5 mg/kg)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg) with capecitabine and bevacizumab
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo with capecitabine and bevacizumab
Number of subjects: 133
Study: 32437629

Group type: EXPERIMENTAL
Intervention: Alliance Project gatekeeper training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 0
Study: 32828570

Group type: EXPERIMENTAL
Intervention: Personalized newsletter
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard newsletter
Number of subjects: 120
Study: 35405931

Group type: EXPERIMENTAL
Intervention: Co-ingestion of soft broccoli and rice (SR)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Co-ingestion of hard broccoli and rice (HR)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Soft broccoli prior to rice (S+R)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hard broccoli prior to rice (H+R)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rice (R)
Number of subjects: 14
Study: 33474798

Group type: EXPERIMENTAL
Intervention: Equivalence probability weighted power prior
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard methods (modified power prior, commensurate prior, robust mixture prior)
Number of subjects: 0
Study: 34949156

Group type: EXPERIMENTAL
Intervention: Treatment as usual with systematic client feedback (SCF) based on the Partners for Change Outcome Management System (PCOMS)
Number of subjects: 1733

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 1733